Cancer drug price hike is back in focus as Indian pharmaceutical companies have sought a sharp increase in prices of key chemotherapy medicines, citing a surge in platinum costs that is hurting production viability.
UPSIDA & JNPA pact is set to reshape India’s pharma export landscape. The Uttar Pradesh State Industrial Development Authority (UPSIDA) partners with Jawaharlal Nehru Port Authority (JNPA) to position the Lalitpur Pharma Park as a global export hub.
India pharma exports have crossed the $28 billion mark in FY26, highlighting the sector’s resilience and steady growth despite global economic uncertainties.
Himachal Pradesh Chief Minister Sukhvinder Singh Sukhu inaugurated the Nuclear Medicine Block with PET scan at IGMC Shimla today, marking a major upgrade in the state’s public healthcare system.
Aurobindo Pharma has approved the generic formulations transfer of its domestic branded generic formulations products business to its wholly owned subsidiary, Auropharm.
AstraZeneca liver cancer therapy is making headlines after the company reported positive Phase III results, showing its combination approach significantly slows disease progression in patients.
US tariffs on patented pharma imports bring mixed impact for India, protecting generics but raising long-term risks for supply chains and investments.
Emami has signed a deal to acquire full stake in Axiom Ayurveda, marking its entry into the fast-growing health and wellness beverage segment.
India bioeconomy growth stands at USD 165.7 billion based on the latest government data, driven by biotech startups, policy support, and manufacturing push, strengthening its role in economic expansion.
Bayer simplifies access to Eylea 2mg in India, enabling early treatment for retinal diseases like Wet AMD and DME, improving patient access and reducing cost barriers.
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")